Synairgen (LON:SNG) Stock Price Passes Below 200-Day Moving Average – Here’s What Happened

Synairgen plc (LON:SNG) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 3.54 ($0.04) and traded as low as GBX 2.01 ($0.03). Synairgen shares last traded at GBX 2.06 ($0.03), with a volume of 308,632 shares.

Synairgen Stock Performance

The stock’s 50-day moving average is GBX 2.42 and its two-hundred day moving average is GBX 3.54. The stock has a market cap of £20.14 million, a PE ratio of -1.24 and a beta of -2.23.

Synairgen Company Profile

Synairgen is a respiratory drug discovery and development company founded by University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic. The business, focused primarily on lung viral defence in asthma and COPD, uses its differentiating human biology BioBank platform and world-renowned international academic KOL network to discover and develop novel therapies for respiratory disease.

Synairgen is conducting a double blind, placebo-controlled clinical trial in COVID-19 patients (SG016).